Key statistics
On Friday, United Therapeutics Corp (U2TH34:SAO) closed at 97.30, -5.07% below its 52-week high of 102.50, set on Aug 29, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 97.30 |
---|---|
High | 97.30 |
Low | 97.30 |
Bid | 94.81 |
Offer | 98.99 |
Previous close | 95.22 |
Average volume | 365.56 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Sep 20 2024 17:49 BST.
More ▼
Press releases
- United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind—Ever
- United Therapeutics Corporation to Present at Upcoming Investor Conferences
- United Therapeutics Corporation Reports Second Quarter 2024 Financial Results
- United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024
- United Therapeutics Corporation Announces Full Enrollment of the TETON 2 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis
- United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors
More ▼